Linaclotide: A New Option for the Treatment of Irritable Bowel syndrome with Constipation and Chronic Idiopathic Constipation in Adults
Chronic idiopathic constipation (CC) and irritable bowel syndrome with predominant constipation (IBS-C) are the 2 most common conditions among functional gastrointestinal disorders. Despite current multiple therapeutic options, treatment remains challenging and dissatisfactory to many patients. Lina...
Main Authors: | Colleen H. Parker, Yuhong Yuan, Louis Wing Cheong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-01-01
|
Series: | Clinical Medicine Insights: Gastroenterology |
Online Access: | https://doi.org/10.4137/CGast.S10550 |
Similar Items
-
Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation in Adults
by: Colleen H. Parker, et al.
Published: (2013-07-01) -
Linaclotide in the treatment of patients with irritable bowel syndrome and constipation: analysis of an opportunity
by: Fernando Carballo
Published: (2013-06-01) -
Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
by: Patel S, et al.
Published: (2021-04-01) -
UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
by: Yan Yiannakou, et al.
Published: (2018-09-01) -
Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide
by: Chandar AK
Published: (2017-10-01)